As Nrf2 activation in astrocytes is known to undergo changes in the human demyelinating disease multiple sclerosis (MS)19,38,39, we investigated whether this was associated with altered cholesterol biosynthesis pathway activation. The gene discussed is NFE2L2; the disease is CNS demyelinating autoimmune disease.